RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
The Latest on: Viral diseases
- PET imaging tracks Zika virus infection, disease progression in mouse model on September 19, 2017 at 3:56 pm
For the first time, scientists have used Positron Emission Tomography (PET) imaging to study brain inflammation following Zika virus infection in mice, according to a study recently published online in the journal Molecular Imaging and Biology. The ... […]
- Research details developments in the Global infectious disease diagnostics market forecast to 2024 on September 19, 2017 at 2:57 am
The Infectious Disease Diagnostics Market accounted to USD 12.6 billion in 2016 growing at a CAGR of 8% during the forecast period of 2017 to 2024. By product type the infectious disease diagnostics market is segmented into instruments and analyzers ... […]
- Global Infectious Diseases Partnering 20102017: Deal trends, players and financials [Report Updated: 01092017] Prices from USD $3495 on September 19, 2017 at 2:57 am
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst... Bioscience - any of the sciences that deal with living ... […]
- CDC Releases New List Of STDs With Many Newly Added Viruses on September 18, 2017 at 2:11 pm
According to a new report by the Centers for Disease Control and Prevention, at least 27 viruses, including Ebola and Marburg, have now been added to the list of Sexually Transmitted Diseases, or STDs. […]
- Infectious Diseases A-Z: Mosquitoes after the hurricanes on September 18, 2017 at 1:14 pm
Dr. Pritish Tosh, an infectious diseases specialist, discusses post-hurricane concerns of increased populations of mosquitoes and mosquito-borne diseases. Luther Strange and Roy Moore are in a Republican primary runoff for a U.S. Senate seat representing ... […]
- Bill Gates thinks an infectious disease outbreak could kill 30 million people at some point in the next decade — here’s how worried you should be on September 18, 2017 at 9:43 am
As hurricanes and other natural disasters ravage the world and the threat of nuclear war looms, it's hard to assess which risks for humanity are really the scariest right now. But one of the biggest threats out there is one of the oldest: infectious ... […]
- Gates invests in Immunocore to spur infectious disease R&D on September 18, 2017 at 8:50 am
The Bill & Melinda Gates Foundation is investing up to $40 million in Immunocore to spur research into the use of T cell receptor (TCR)-based therapeutics to treat tuberculosis and HIV. Immunocore is primarily known for its work in cancer. That is what ... […]
- ED Infectious Disease Drills Show Room for Improvement on September 18, 2017 at 1:00 am
In unannounced mystery-patient infectious disease drills at hospital emergency departments (EDs), staff correctly put patients in masks and isolation 78% of the time. However, only 36% of staff performed personal hand hygiene, and even fewer (16% ... […]
- Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases on September 17, 2017 at 11:29 pm
$40 million investment to accelerate development of Immunocore's ImmTAV® and ImmTAB® therapeutics for infectious diseases, in particular tuberculosis and HIV (Oxford, UK and Conshohocken, US, 18 September 2017) Immunocore Limited, the world's leading TCR ... […]
- Cancer and Other Dangerous Diseases Vaccines Could Prevent By 2027 on September 17, 2017 at 7:29 am
That could change soon. According to the National Institute of Allergy and Infectious Diseases, like they’re doing with malaria, scientists are investigating the relationship between immune responses and the Zika virus. Since researchers have studied ... […]
via Google News and Bing News